Eclipse Enterogenesis, Inc.
Publicly observedMenlo Park, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Menlo Park | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Eclipse Enterogenesis, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | NNJ5XHMGNKS8 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant12 Jul 2021Publicly observed
NIH SBIR/STTR award: Outcomes study for the XL1 distraction enterogenesis device to improve nutrient absorption in short bowel syndrome patients
USD 860,948.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant12 Jul 2021Publicly observed
NIH SBIR/STTR award: Outcomes study for the XL1 distraction enterogenesis device to improve nutrient absorption in short bowel syndrome patients
USD 856,731.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.